The Committee for Medicinal Products for Human Use (CHMP) is the committee that is responsible for preparing the Agency's opinions on all questions concerning human medicines.
European Medicines Agency, Amsterdam, the Netherlands
Start date:
19 February 2024
End date:
22 February 2024
EventHumanMedicines
Online
Start date:
14 February 2024, 10:00 (CET)
End date:
14 February 2024, 13:30 (CET)
EventHumanMedicine shortages
The Committee for Advanced Therapies (CAT) is the committee that is responsible for assessing the quality, safety and efficacy of advanced-therapy medicines.
European Medicines Agency, Amsterdam, the Netherlands
Start date:
14 February 2024
End date:
16 February 2024
EventHumanAdvanced therapiesInnovation
Online
Start date:
13 February 2024, 10:00 (CET)
End date:
13 February 2024, 11:30 (CET)
EventHumanMedicines
The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.
European Medicines Agency, Amsterdam, the Netherlands
Start date:
13 February 2024
End date:
15 February 2024
EventHumanRare diseases
The Committee for Medicinal Products for Veterinary Use (CVMP) is the committee that is responsible for preparing the Agency's opinions on all questions concerning veterinary medicines.
European Medicines Agency, Amsterdam, the Netherlands
Start date:
13 February 2024
End date:
15 February 2024
EventVeterinaryMedicines
European Medicines Agency, Amsterdam, the Netherlands
Start date:
12 February 2024, 09:00 (CET)
End date:
15 February 2024, 13:30 (CET)
EventHumanClinical trials
European Medicines Agency, Amsterdam, the Netherlands
Start date:
12 February 2024
End date:
13 February 2024
EventHumanCorporateMedicines
Online
European Medicines Agency, Amsterdam, the Netherlands
Live broadcast
Start date:
9 February 2024, 10:00 (CET)
End date:
9 February 2024, 13:00 (CET)
EventHumanClinical trials
EMA and EFPIA met in the context of EMA's annual bilateral meetings with industry stakeholder organisations
European Medicines Agency, Amsterdam, the Netherlands
Start date:
6 February 2024
End date:
6 February 2024
EventHumanMedicines